A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer

M. C. Alonso, J. M. Tabernero, B. Ojeda, M. Llanos, C. Solà, M. A. Climent, M. A. Seguí, J. J. López

    Research output: Contribution to journalArticleResearchpeer-review

    25 Citations (Scopus)

    Fingerprint Dive into the research topics of 'A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer'. Together they form a unique fingerprint.

    Medicine & Life Sciences